Сlinic and pathogenic significance of omentin

Posted on by adminLeave a comment

Prof. Korzh O.M., asst. Fylenko Y.M.

Kharkiv National Medical University

Today, adipokines are important cellular signaling proteins synthesized by adipose tissue and involved in a variety of processes, including inflammation, lipid and glucose metabolism, insulin sensitivity, endothelial cell function, angiogenesis, blood pressure regulation, and many others. This review examines the immunological and endocrine function of omentin and its potential use as a biomarker and therapeutic target in diseases such as diabetes, chronic kidney disease, cardiovascular disease, and atherosclerosis.

Key words: adipokines, omentin, diabetes, cardiovascular diseases, chronic kidney disease.

 https://doi.org/10.15407/internalmed2023.02.095

Download.PDF (ukr)

Cite:

  1. Корж, O.M. Клініко-патогенетичне значення оментину / О.М. Корж, Я.М. Филенко // Східноєвропейський журнал внутрішньої та сімейної медицини. – 2023. – № 2. – С. 95-98. http://doi.org/10.15407/internalmed2023.02.095
  2. Korzh OM, Fylenko YM. [Сlinic and pathogenic significance of omentin]. Shidnoevr. z. vnutr. simejnoi med. 2023;2:95-98. Ukrainian. http://doi.org/10.15407/internalmed2023.02.095

References:

  1. Zhou Y, Zhang B, Hao C, Huang X, Li X, Huang Y, Luo Z. Omentin-A Novel Adipokine in Respiratory Diseases. International Journal of Molecular Sciences. 2017;19(1):73. http://dx.doi.org/10.3390/ijms19010073
  2. Yang R, Lee M, Hu H, Pray J, Wu H, Hansen B, Shuldiner A, Fried S, McLenithan J, Gong D. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American Journal of Physiology-Endocrinology and Metabolism. 2006;290(6):E1253-E1261. http://dx.doi.org/10.1152/ajpendo.00572.2004
  3. Greulich S, Chen W, Maxhera B, Rijzewijk L, van der Meer R, Jonker J, Mueller H, de Wiza D, Floerke R, Smiris K, Lamb H, de Roos A, Bax J, Romijn J, Smit J, Akhyari P, Lichtenberg A, Eckel J, Diamant M, Ouwens D. Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and In Vitro Studies. PLoS ONE. 2013;8(3):e59697. http://dx.doi.org/10.1371/journal.pone.0059697
  4. Senthilkumar G, Anithalekshmi M, Yasir M, Parameswaran S, Packirisamy R, Bobby Z. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;12(1):23-26. http://dx.doi.org/10.1016/j.dsx.2017.08.005
  5. Matsuo K, Shibata R, Ohashi K, Kambara T, Uemura Y, Hiramatsu-Ito M, Enomoto T, Yuasa D, Joki Y, Ito M, Hayakawa S, Ogawa H, Kihara S, Murohara T, Ouchi N. Omentin functions to attenuate cardiac hypertrophic response. Journal of Molecular and Cellular Cardiology. 2015;79:195-202. http://dx.doi.org/10.1016/j.yjmcc.2014.11.019
  6. Yang R, Lee M, Hu H, Pray J, Wu H, Hansen B, Shuldiner A, Fried S, McLenithan J, Gong D. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American Journal of Physiology-Endocrinology and Metabolism. 2006;290(6):E1253-E1261. http://dx.doi.org/10.1152/ajpendo.00572.2004
  7. Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. International Journal of Obesity. 2002;26(2):193-199. http://dx.doi.org/10.1038/sj.ijo.0801871
  8. de Souza Batista C, Yang R, Lee M, Glynn N, Yu D, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried S, Gong D, Shuldiner A, Pollin T, McLenithan J. Omentin Plasma Levels and Gene Expression Are Decreased in Obesity. Diabetes. 2007;56(6):1655-1661. http://dx.doi.org/10.2337/db06-1506
  9. Landecho M, Tuero C, Valentí V, Bilbao I, de la Higuera M, Frühbeck G. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk. Nutrients. 2019;11(11):2664. http://dx.doi.org/10.3390/nu11112664
  10. Neeland I, Poirier P, Després J. Cardiovascular and Metabolic Heterogeneity of Obesity. Circulation. 2018;137(13):1391-1406. http://dx.doi.org/10.1161/circulationaha.117.029617
  11. González N, Moreno-Villegas Z, González-Bris A, Egido J, Lorenzo Ó. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovascular Diabetology. 2017;16(1):. http://dx.doi.org/10.1186/s12933-017-0528-4
  12. Packer M. Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium. Journal of the American College of Cardiology. 2018;71(20):2360-2372. http://dx.doi.org/10.1016/j.jacc.2018.03.509
  13. Zhou M, Wang H, Chen J, Zhao L. Epicardial adipose tissue and atrial fibrillation: Possible mechanisms, potential therapies, and future directions. Pacing and Clinical Electrophysiology. 2019;43(1):133-145. http://dx.doi.org/10.1111/pace.13825
  14. Wang M, Zhao L, Liang H, Zhang C, Guan L, Li M. A new measurement site for echocardiographic epicardial adipose tissue thickness and its value in predicting metabolic syndrome. Advances in Clinical and Experimental Medicine. 2019;28(10):1403-1408. http://dx.doi.org/10.17219/acem/104526
  15. Hu H, Garcia-Barrio M, Jiang Z, Chen Y, Chang L. Roles of Perivascular Adipose Tissue in Hypertension and Atherosclerosis. Antioxidants & Redox Signaling. 2021;34(9):736-749. http://dx.doi.org/10.1089/ars.2020.8103
  16. DeVallance E, Branyan K, Lemaster K, Anderson R, Marshall K, Olfert I, Smith D, Kelley E, Bryner R, Frisbee J, Chantler P. Exercise training prevents the perivascular adipose tissue-induced aortic dysfunction with metabolic syndrome. Redox Biology. 2019;26:101285. http://dx.doi.org/10.1016/j.redox.2019.101285
  17. Zhu Q, Scherer P. Immunologic and endocrine functions of adipose tissue: implications for kidney disease. Nature Reviews Nephrology. 2017;14(2):105-120. http://dx.doi.org/10.1038/nrneph.2017.157
  18. Tekce H, Tekce B, Aktas G, Alcelik A, Sengul E. Serum Omentin-1 Levels in Diabetic and Nondiabetic Patients with Chronic Kidney Disease. Experimental and Clinical Endocrinology & Diabetes. 2014;122(08):451-456. http://dx.doi.org/10.1055/s-0034-1375674
  19. Moemeni H, Qujeq D, Ahmadi Ahangar A, Hajian K, Parsian H. Evaluation of Serum Magnesium, Iron, Copper and Zinc Levels in Ischemic and Hemorrhagic Stroke Patients and Healthy Controls. Journal of Clinical and Basic Research. 2018;2(1):6-10. http://dx.doi.org/10.29252/jcbr.2.1.6